Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: possible involvement in osteoarthritis pain

IntroductionNerve growth factor (NGF) level is increased in osteoarthritis (OA) joints and is involved in pain associated with OA. Stimuli responsible for NGF stimulation in chondrocytes are unknown. We investigated whether mechanical stress and proinflammatory cytokines may influence NGF synthesis by chondrocytes.MethodsPrimary cultures of human OA chondrocytes, newborn mouse articular chondrocytes or cartilage explants were stimulated by increasing amounts of IL-1β, prostaglandin E2 (PGE2), visfatin/nicotinamide phosphoribosyltransferase (NAMPT) or by cyclic mechanical compression (0.5 Hz, 1 MPa). Before stimulation, chondrocytes were pretreated with indomethacin, Apo866, a specific inhibitor of NAMPT enzymatic activity, or transfected by siRNA targeting visfatin/NAMPT. mRNA NGF levels were assessed by real-time quantitative PCR and NGF released into media was determined by ELISA.ResultsUnstimulated human and mouse articular chondrocytes expressed low levels of NGF (19.2 ± 8.7 pg/mL, 13.5 ± 1.0 pg/mL and 4.4 ± 0.8 pg/mL/mg tissue for human and mouse articular chondrocytes and costal explants, respectively). Mechanical stress induced NGF release in conditioned media. When stimulated by IL-1β or visfatin/NAMPT, a proinflammatory adipokine produced by chondocytes in response to IL-1β, a dose-dependent increase in NGF mRNA expression and NGF release in both human and mouse chondrocyte conditioned media was observed. Visfatin/NAMPT is also an intracellular enzyme acting as the rate-limiting enzyme of the generation of NAD. The expression of NGF induced by visfatin/NAMPT was inhibited by Apo866, whereas IL-1β-mediated NGF expression was not modified by siRNA targeting visfatin/NAMPT. Interestingly, PGE2, which is produced by chondrocytes in response to IL-1β and visfatin/NAMPT, did not stimulate NGF production. Consistently, indomethacin, a cyclooxygenase inhibitor, did not counteract IL-1β-induced NGF production.ConclusionsThese results show that mechanical stress, IL-1β and extracellular visfatin/NAMPT, all stimulated the expression and release of NGF by chondrocytes and thus suggest that the overexpression of visfatin/NAMPT and IL-1β in the OA joint and the increased mechanical loading of cartilage may mediate OA pain via the stimulation of NGF expression and release by chondrocytes.

[1]  L. Manni,et al.  Role of IL-1b and TNF-a in the regulation of NGF in experimentally induced arthritis in mice , 1998, Rheumatology International.

[2]  Zhihong Wu,et al.  Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis , 2012, Rheumatology International.

[3]  L. Rodríguez-Mañas,et al.  Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity , 2009, Diabetologia.

[4]  S. Ohtori,et al.  Role of low-affinity nerve growth factor receptor inhibitory antibody in reducing pain behavior and calcitonin gene-related Peptide expression in a rat model of wrist joint inflammatory pain. , 2010, The Journal of hand surgery.

[5]  E. Schwarz,et al.  Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. , 2005, Biochemical and biophysical research communications.

[6]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[7]  W. Steers,et al.  Stretch‐activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats , 2000, Journal of cellular physiology.

[8]  R. Levi‐montalcini,et al.  Nerve growth factor and distribution of mast cells in the synovium of adult rats. , 1992, Clinical and experimental rheumatology.

[9]  S. Fiorito,et al.  Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. , 2003, Clinical and experimental rheumatology.

[10]  U. Schotten,et al.  Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. , 2009, Journal of molecular and cellular cardiology.

[11]  A. Freemont,et al.  Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc , 2008, Arthritis research & therapy.

[12]  O. Leo,et al.  Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD , 2008, PloS one.

[13]  M. Kvarnström,et al.  Interleukin-1beta in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[14]  F. Berenbaum,et al.  Synergistic Effect of Interleukin-1β and Tumor Necrosis Factor α on PGE2Production by Articular Chondrocytes Does Not Involve PLA2Stimulation , 1996 .

[15]  F. Berenbaum,et al.  Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation. , 1996, Experimental Cell Research.

[16]  B. Fredholm,et al.  Mechanisms of nerve growth factor mRNA regulation by interleukin‐1β in hippocampal cultures: Role of second messengers , 1992, Journal of neuroscience research.

[17]  E. Vignon,et al.  When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program , 2016, Arthritis & rheumatology.

[18]  I. Davignon,et al.  Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial. , 2012, The journal of pain : official journal of the American Pain Society.

[19]  J. Gómez-Reino,et al.  What's new in our understanding of the role of adipokines in rheumatic diseases? , 2011, Nature Reviews Rheumatology.

[20]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[21]  T. Schnitzer,et al.  Tanezumab for the treatment of pain from osteoarthritis of the knee. , 2010, The New England journal of medicine.

[22]  M. Feldmann,et al.  Treatmentof murine osteoarthritis withTrkAd5 reveals a pivotal rolefor nerve growth factor in non-inflammatory joint pain , 2010, PAIN®.

[23]  S. B. Pedersen,et al.  Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation. , 1999, Prostaglandins & other lipid mediators.

[24]  F. Berenbaum,et al.  Proinflammatory Actions of Visfatin/Nicotinamide Phosphoribosyltransferase (Nampt) Involve Regulation of Insulin Signaling Pathway and Nampt Enzymatic Activity* , 2012, The Journal of Biological Chemistry.

[25]  M. Bulló,et al.  Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2. , 2005, American journal of physiology. Endocrinology and metabolism.

[26]  R. Levi‐montalcini,et al.  Nerve growth factor in the synovial fluid of patients with chronic arthritis. , 1992, Arthritis and rheumatism.

[27]  R. Seerattan,et al.  Nerve growth factor improves ligament healing , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  O. Grimsholm,et al.  Expression Patterns of Neurotrophins and Neurotrophin Receptors in Articular Chondrocytes and Inflammatory Infiltrates in Knee Joint Arthritis , 2008, Cells Tissues Organs.

[29]  R. Terkeltaub,et al.  The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study , 2009, Annals of the rheumatic diseases.

[30]  M. Seidel,et al.  Nerve growth factor in rheumatic diseases. , 2010, Seminars in arthritis and rheumatism.

[31]  L. Manni,et al.  Role of IL-1 beta and TNF-alpha in the regulation of NGF in experimentally induced arthritis in mice. , 1998, Rheumatology international.

[32]  C. Patry,et al.  Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture , 1996, British journal of pharmacology.

[33]  F. Sohrabji,et al.  The neurotrophin receptor p75NTR mediates early anti-inflammatory effects of estrogen in the forebrain of young adult rats , 2005, BMC Neuroscience.

[34]  Simon A. Jones,et al.  Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthritis. , 2011, Arthritis and rheumatism.

[35]  F. Berenbaum,et al.  Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene , 2006, Arthritis research & therapy.

[36]  M. Hochberg,et al.  New treatments for osteoarthritis , 2013, Current opinion in rheumatology.

[37]  F. Berenbaum,et al.  Mechanical stress and prostaglandin E2 synthesis in cartilage. , 2008, Biorheology.

[38]  J. E. Lee,et al.  The role of nerve growth factor in hyperosmolar stress induced apoptosis , 2008, Journal of cellular physiology.

[39]  Janine Wehrhahn,et al.  Review: NAD + : A modulator of immune functions , 2011, Innate immunity.

[40]  F. Greco,et al.  Expression of NGF, Trka and p75 in human cartilage. , 2009, European journal of histochemistry : EJH.

[41]  L. Ma,et al.  Nerve growth factor induced after temporomandibular joint inflammation decelerates chondrocyte differentiation. , 2013, Oral diseases.

[42]  Li-Dong Wu,et al.  Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis , 2010, Clinical chemistry and laboratory medicine.

[43]  Kaori Matsumoto,et al.  Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures , 2004, FEBS letters.

[44]  J. Krueger,et al.  Cytokine mRNA induction by interleukin-1β or tumor necrosis factor α in vitro and in vivo , 2008, Brain Research.

[45]  U. Scapagnini,et al.  Nerve growth factor inhibits some acute experimental inflammations. , 1989, Archives internationales de pharmacodynamie et de therapie.

[46]  I. Davignon,et al.  Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial. , 2013, Arthritis and rheumatism.

[47]  P. Hawkins,et al.  Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study , 2011, Arthritis research & therapy.

[48]  Max Hasmann,et al.  FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. , 2003, Cancer research.

[49]  A. Leonardi,et al.  The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. , 2012, Thrombosis research.

[50]  F. Berenbaum,et al.  Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. , 2008, Arthritis and rheumatism.

[51]  F. Berenbaum,et al.  Osteoarthritis, inflammation and obesity , 2013, Current opinion in rheumatology.

[52]  P. Schauerte,et al.  Mechanical stretch induces nerve sprouting in rat sympathetic neurocytes , 2010, Autonomic Neuroscience.

[53]  F. Berenbaum,et al.  Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. , 2005, Osteoarthritis and cartilage.

[54]  Stefan Fischer,et al.  Compartmentation of NAD+‐dependent signalling , 2011, FEBS letters.

[55]  Haeyoun Kang,et al.  Interleukin‐1β induces angiogenesis and innervation in human intervertebral disc degeneration , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[56]  Jonathan Samuels,et al.  Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. , 2011, Arthritis and rheumatism.

[57]  M. Kvarnström,et al.  Interleukin-1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite , 1998 .

[58]  L. Olson,et al.  Regulation of β‐nerve growth factor expression by inflammatory mediators in hippocampal cultures , 1990, Journal of neuroscience research.

[59]  Adam Sapirstein,et al.  Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity , 2001, Nature.

[60]  Yu-qi Fan,et al.  Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway. , 2011, International journal of molecular medicine.

[61]  C. Fan,et al.  Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes. , 2011, International journal of molecular medicine.

[62]  H. An,et al.  Proinflammatory Cytokines Stimulate the Expression of Nerve Growth Factor by Human Intervertebral Disc Cells , 2007, Spine.

[63]  S. Jabbur,et al.  Inflammatory mediators released following application of irritants on the rat injured incisors. The effect of treatment with anti-inflammatory drugs. , 2009, Cytokine.

[64]  E. Costa,et al.  Beta adrenergic and prostaglandin receptor activation increases nerve growth factor mRNA content in C6-2B rat astrocytoma cells. , 1988, The Journal of pharmacology and experimental therapeutics.

[65]  G. Bianco,et al.  Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. , 2002, Rheumatology.

[66]  H. Yamazaki,et al.  Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff diseases. , 2001, Rheumatology.